Abnormal neuronal networks and seizure susceptibility in mice overexpressing the APP intracellular domain

[1]  Yong Shen,et al.  Alzheimer's disease-like pathological features in transgenic mice expressing the APP intracellular domain , 2009, Proceedings of the National Academy of Sciences.

[2]  S. Thayer,et al.  γ-Secretase activity modulates store-operated Ca2+ entry into rat sensory neurons , 2009, Neuroscience Letters.

[3]  M. Tabaton,et al.  Evidence that the Amyloid beta Precursor Protein-intracellular domain lowers the stress threshold of neurons and has a "regulated" transcriptional role , 2008, Molecular Neurodegeneration.

[4]  Christopher C. J. Miller,et al.  The FE65 proteins and Alzheimer's disease , 2008, Journal of neuroscience research.

[5]  Simon Lovestone,et al.  The GSK3 hypothesis of Alzheimer's disease , 2008, Journal of neurochemistry.

[6]  Anatol C. Kreitzer,et al.  Aberrant Excitatory Neuronal Activity and Compensatory Remodeling of Inhibitory Hippocampal Circuits in Mouse Models of Alzheimer's Disease , 2007, Neuron.

[7]  S. Heinemann,et al.  Deficits in Synaptic Transmission and Learning in Amyloid Precursor Protein (APP) Transgenic Mice Require C-Terminal Cleavage of APP , 2006, The Journal of Neuroscience.

[8]  D. Bredesen,et al.  Correction for Galvan et al., Reversal of Alzheimer's-like pathology and behavior in human APP transgenic mice by mutation of Asp664 , 2006, Proceedings of the National Academy of Sciences.

[9]  S. Pimplikar,et al.  Activation of GSK-3 and phosphorylation of CRMP2 in transgenic mice expressing APP intracellular domain , 2005, The Journal of cell biology.

[10]  M. Bothwell,et al.  Familial Alzheimer's disease mutations inhibit γ‐secretase‐mediated liberation of β‐amyloid precursor protein carboxy‐terminal fragment , 2005 .

[11]  B. de Strooper,et al.  β Subunits of Voltage-gated Sodium Channels Are Novel Substrates of β-Site Amyloid Precursor Protein-cleaving Enzyme (BACE1) and γ-Secretase* , 2005, Journal of Biological Chemistry.

[12]  M. Menéndez.  Down syndrome, Alzheimer's disease and seizures , 2005, Brain and Development.

[13]  Steven J Novick,et al.  Increased seizure threshold and severity in young transgenic CRND8 mice , 2004, Neuroscience Letters.

[14]  H. Tanila,et al.  Alteration of cortical EEG in mice carrying mutated human APP transgene , 2002, Brain Research.

[15]  T. Russo,et al.  Fe65 and the protein network centered around the cytosolic domain of the Alzheimer's β‐amyloid precursor protein , 1998, FEBS letters.

[16]  D. Price,et al.  Altered metabolism of familial Alzheimer's disease-linked amyloid precursor protein variants in yeast artificial chromosome transgenic mice. , 1997, Human molecular genetics.

[17]  R. Racine,et al.  Modification of seizure activity by electrical stimulation. 3. Mechanisms. , 1972, Electroencephalography and clinical neurophysiology.

[18]  R. Racine,et al.  Modification of seizure activity by electrical stimulation. II. Motor seizure. , 1972, Electroencephalography and clinical neurophysiology.

[19]  M. Bothwell,et al.  Familial Alzheimer's disease mutations inhibit gamma-secretase-mediated liberation of beta-amyloid precursor protein carboxy-terminal fragment. , 2005, Journal of neurochemistry.

[20]  D. Price,et al.  Mutant genes in familial Alzheimer's disease and transgenic models. , 1998, Annual review of neuroscience.

[21]  R. Racine.  Modification of seizure activity by electrical stimulation: cortical areas. , 1975, Electroencephalography and clinical neurophysiology.